Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mark Tompkins

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Vaccine|November 15, 2011
Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced doseJennifer Humberd Smith, Mark Papania, Darin Knaus, et al.
ACS Central Science|July 8, 2021
Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2Lin Liu, Pradeep Chopra, Xiuru Li, et al.
The Journal of General Virology|April 13, 2013
Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infectionJulie M Fox, Leo K Sage, Lei Huang, et al.
Journal of Virology|October 19, 2012
Recombinant parainfluenza virus 5 expressing hemagglutinin of influenza A virus H5N1 protected mice against lethal highly pathogenic avian influenza virus H5N1 challengeZhuo Li, Alaina J Mooney, Jon D Gabbard, et al.
Vaccine|February 9, 2011
Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in miceJennifer Humberd Smith, Paula Brooks, Scott Johnson, et al.
Journal of Virology|December 3, 2020
Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza ALynn Bimler, Sydney L Ronzulli, Amber Y Song, et al.
Mbio|July 19, 2018
Moving Forward: Recent Developments for the Ferret Biomedical Research ModelRandy A Albrecht, Wen-Chun Liu, Andrea J Sant, et al.
Journal of Virology|June 27, 2014
Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivoOlivia Perwitasari, Scott Johnson, Xiuzhen Yan, et al.
Journal of Virology|September 27, 2022
Correction for Bimler et al., "Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A"Lynn Bimler, Sydney L Ronzulli, Amber Y Song, et al.
Cell Reports|January 30, 2026
PD-L1 is an intrinsic switch for natural killer cell-mediated, TRAIL-dependent antiviral functionKayla Frank, Himani Sharma, Efthymios Motakis, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Vaccine|November 15, 2011
Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced doseJennifer Humberd Smith, Mark Papania, Darin Knaus, et al.
ACS Central Science|July 8, 2021
Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2Lin Liu, Pradeep Chopra, Xiuru Li, et al.
The Journal of General Virology|April 13, 2013
Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infectionJulie M Fox, Leo K Sage, Lei Huang, et al.
Journal of Virology|October 19, 2012
Recombinant parainfluenza virus 5 expressing hemagglutinin of influenza A virus H5N1 protected mice against lethal highly pathogenic avian influenza virus H5N1 challengeZhuo Li, Alaina J Mooney, Jon D Gabbard, et al.
Vaccine|February 9, 2011
Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in miceJennifer Humberd Smith, Paula Brooks, Scott Johnson, et al.
Journal of Virology|December 3, 2020
Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza ALynn Bimler, Sydney L Ronzulli, Amber Y Song, et al.
Mbio|July 19, 2018
Moving Forward: Recent Developments for the Ferret Biomedical Research ModelRandy A Albrecht, Wen-Chun Liu, Andrea J Sant, et al.
Journal of Virology|June 27, 2014
Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivoOlivia Perwitasari, Scott Johnson, Xiuzhen Yan, et al.
Journal of Virology|September 27, 2022
Correction for Bimler et al., "Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A"Lynn Bimler, Sydney L Ronzulli, Amber Y Song, et al.
Cell Reports|January 30, 2026
PD-L1 is an intrinsic switch for natural killer cell-mediated, TRAIL-dependent antiviral functionKayla Frank, Himani Sharma, Efthymios Motakis, et al.
Pageof 10